Abstract
Cytochromes P450 are heme containing enzymes that catalyze numerous oxidation reactions including hydroxylation of non-activated CH-bonds, epoxidation, dealkylation and even C-C bond cleavage. Along with their broad substrate spectrum, P450s often possess high regio-, chemo-, and stereoselectivity, thereby playing an essential role in metabolism. Due to their versatility P450s are the rising stars in biotechnological applications and synthetic biology.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Literatur
Bernhardt R (2006) Cytochromes P450 as versatile biocatalysts. J Biotechnol 124:128–145
Bernhardt R, Urlacher VB (2014) Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations. Appl Microbiol Biotechnol 98:6185–6203
Omura T (2018) Future perception in P450 research. J Inorg Biochem 186:264–266
Nelson DR (2018) Cytochrome P450 diversity in the tree of life. Biochim Biophys Acta Proteins Proteom 1866:141–154
Schiffer L, Brixius-Anderko S, Hannemann F et al. (2016) Metabolism of oral turinabol by human steroid hormone-synthesizing cytochrome P450 enzymes. Drug Metab Dispos 44:227–237
Schiffer L, Muller AR, Hobler A et al. (2016) Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: characterization of the products and their influence on mineralocorticoid receptor transactivation. J Steroid Biochem Mol Biol 163:68–76
Rendic S, Guengerich FP (2015) Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals. Chem Res Toxicol 28:38–42
Meyer UA (1996) Overview of enzymes of drug metabolism. J Pharmacokinet Biopharm 24:449–459
Ingelman-Sundberg M, Sim SC, Gomez A et al. (2007) Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496–526
Schuster I, Bernhardt R (2007) Inhibition of cytochromes p450: existing and new promising therapeutic targets. Drug Metab Rev 39:481–499
Litzenburger M, Kern F, Khatri Y et al. (2015) Conversions of tricyclic antidepressants and antipsychotics with selected P450s from Sorangium cellulosum So ce56. Drug Metab Dispos 43:392–399
Worsch A, Eggimann FK, Girhard M et al. (2018) A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s. Biotechnol Bioeng 115:2156–2166
Zhang K, Shafer BM, Demars MD et al. (2012) Controlled oxidation of remote sp3 C-H bonds in artemisinin via P450 catalysts with fine-tuned regio- and stereoselectivity. J Am Chem Soc 134:18695–18704
Le-Huu P, Heidt T, Claasen B et al. (2015) Chemo-, regio-,and stereoselective oxidation of the monocyclic diterpenoid β-cembrenediol by P450 BM3. ACS Catalysis 5:1772–1780
Brandenberg OF, Fasan R, Arnold FH (2017) Exploiting and engineering hemoproteins for abiological carbene and nitrene transfer reactions. Curr Opin Biotechnol 47:102–111
Paddon CJ, Keasling JD (2014) Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat Rev Microbiol 12:355–367
Ajikumar PK, Xiao WH, Tyo KEJ et al. (2010) Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 330:70–74
Urlacher VB, Girhard M (2019) Cytochrome P450 monooxygenases in biotechnology and synthetic biology. Trends Biotechnol 37:882–897
Author information
Authors and Affiliations
Corresponding authors
Additional information
Vlada B. Urlacher 1988–1993 Biologiestudium an der Staatlichen Universität Taschkent, Usbekistan. 1993–1996 Promotion am Institut für Mikrobiologie, Akademie der Wissenschaft, Usbekistan. 1997–1998 Postdoktorandin am Institut für Technische Biochemie, Universität Stuttgart. 1999–2000 Postdoktorandin am Institut für Biochemie und Biotechnologie, Universität Halle-Wittenberg. 2001–2009 Gruppenleiterin am Institut für Technische Biochemie, Universität Stuttgart; dort 2008 Habilitation für das Fach Molekulare Biotechnologie. Seit 2010 Professorin für Biochemie an der Universität Düsseldorf.
Rita Bernhardt 1969–1973 Biochemiestudium an der Universität Halle-Wittenberg. 1973–1977 Aspirantur an der Staatlichen Lomonossow-Universität Moskau. 1977–1991 Mit -arbeiterin am Zentralinstitut für Molekularbiologie, Berlin-Buch. 1992–1995 Projektleiterin am Max-Delbrück-Centrum, Berlin-Buch. 1995–2016 Lehrstuhlinhaberin für Biochemie an der Universität des Saarlandes. Seit 2016 Seniorprofessorin ebendort.
Rights and permissions
About this article
Cite this article
Urlacher, V.B., Bernhardt, R. Cytochrome P450 — vielseitige Enzyme für Medizin und Biotechnologie. Biospektrum 25, 715–718 (2019). https://doi.org/10.1007/s12268-019-1303-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-019-1303-8